| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |